CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 22 filers reported holding CANDEL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 1,935,215 | $6,077,000 | 4.26% |
| Sands Capital Ventures, LLC | 811,737 | $2,549,000 | 0.74% |
| Empirical Asset Management, LLC | 12,000 | $38,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,700 | $417,000 | 0.01% |
| Point72 Asset Management, L.P. | 403,131 | $1,266,000 | 0.01% |
| FRANKLIN RESOURCES INC | 1,125,000 | $3,533,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 96 | $0 | 0.00% |
| NORTHERN TRUST CORP | 14,483 | $45,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 128,846 | $404,000 | 0.00% |